BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24270349)

  • 1. An inflammatory mediator, prostaglandin E2, in colorectal cancer.
    Wang D; DuBois RN
    Cancer J; 2013; 19(6):502-10. PubMed ID: 24270349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer.
    Wang D; Cabalag CS; Clemons NJ; DuBois RN
    Gastroenterology; 2021 Dec; 161(6):1813-1829. PubMed ID: 34606846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer.
    Mizuno R; Kawada K; Sakai Y
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Cyclooxygenase-2 in Colorectal Cancer.
    Sheng J; Sun H; Yu FB; Li B; Zhang Y; Zhu YT
    Int J Med Sci; 2020; 17(8):1095-1101. PubMed ID: 32410839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pi (Spleen)-deficiency syndrome in tumor microenvironment is the pivotal pathogenesis of colorectal cancer immune escape.
    Sun XG; Lin XC; Diao JX; Yu ZL; Li K
    Chin J Integr Med; 2016 Oct; 22(10):789-94. PubMed ID: 26556710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation.
    Park A; Lee Y; Kim MS; Kang YJ; Park YJ; Jung H; Kim TD; Lee HG; Choi I; Yoon SR
    Front Immunol; 2018; 9():1859. PubMed ID: 30140269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Prostaglandin E2 in the Progression of Gastrointestinal Cancer.
    Wilson DJ; DuBois RN
    Cancer Prev Res (Phila); 2022 Jun; 15(6):355-363. PubMed ID: 35288737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas.
    Kojima M; Morisaki T; Uchiyama A; Doi F; Mibu R; Katano M; Tanaka M
    Ann Surg Oncol; 2001 Jun; 8(5):458-65. PubMed ID: 11407522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell defects in the colorectal cancer.
    Legitimo A; Consolini R; Failli A; Orsini G; Spisni R
    Hum Vaccin Immunother; 2014; 10(11):3224-35. PubMed ID: 25483675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2.
    Backlund MG; Mann JR; Dubois RN
    Oncology; 2005; 69 Suppl 1():28-32. PubMed ID: 16210874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE
    Loo TM; Kamachi F; Watanabe Y; Yoshimoto S; Kanda H; Arai Y; Nakajima-Takagi Y; Iwama A; Koga T; Sugimoto Y; Ozawa T; Nakamura M; Kumagai M; Watashi K; Taketo MM; Aoki T; Narumiya S; Oshima M; Arita M; Hara E; Ohtani N
    Cancer Discov; 2017 May; 7(5):522-538. PubMed ID: 28202625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer.
    Krishnan K; Ruffin MT; Normolle D; Shureiqi I; Burney K; Bailey J; Peters-Golden M; Rock CL; Boland CR; Brenner DE
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):447-53. PubMed ID: 11352853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells.
    Sheng H; Shao J; Washington MK; DuBois RN
    J Biol Chem; 2001 May; 276(21):18075-81. PubMed ID: 11278548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
    O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
    Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development.
    Ahechu P; Zozaya G; Martí P; Hernández-Lizoáin JL; Baixauli J; Unamuno X; Frühbeck G; Catalán V
    Front Immunol; 2018; 9():2918. PubMed ID: 30619282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonic acid and colorectal carcinogenesis.
    Jones R; Adel-Alvarez LA; Alvarez OR; Broaddus R; Das S
    Mol Cell Biochem; 2003 Nov; 253(1-2):141-9. PubMed ID: 14619964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multi-faceted roles of prostaglandin E2 in cancer-infiltrating mononuclear phagocyte biology.
    Sha W; Brüne B; Weigert A
    Immunobiology; 2012 Dec; 217(12):1225-32. PubMed ID: 22727331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate promotes PGE2 synthesis and gluconeogenesis in monocytes to benefit the growth of inflammation-associated colorectal tumor.
    Wei L; Zhou Y; Yao J; Qiao C; Ni T; Guo R; Guo Q; Lu N
    Oncotarget; 2015 Jun; 6(18):16198-214. PubMed ID: 25938544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of Prostaglandin E2-EP2 Signals in the Colon Tumor Microenvironment That Amplify Inflammation and Tumor Growth.
    Ma X; Aoki T; Tsuruyama T; Narumiya S
    Cancer Res; 2015 Jul; 75(14):2822-32. PubMed ID: 26018088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.